Holly B. Krasa

4.4k citations

46 papers · 3.2k indexed · 1 hit paper · h-index 24

Nephrology top 1%
- Renal Diseases and Glomerulopathies 6
- Dialysis and Renal Disease Management 5
Genetics top 1%
- Genetic and Kidney Cyst Diseases 18
- Genetic Syndromes and Imprinting 4
Pathology and Forensic Medicine top 2%
Behavioral Neuroscience top 5%
Pulmonary and Respiratory Medicine top 5%
- Electrolyte and hormonal disorders 12
Molecular Biology
- Ion Transport and Channel Regulation 7
- Renal and related cancers 5
Psychiatry and Mental health
- Schizophrenia research and treatment 4

Co-authors: Frank S. Czerwiec John Ouyang Vicente E. Torres Arlene B. Chapman Ron T. Gansevoort Ronald D. Perrone Eiji Higashihara Jared J. Grantham
Cited by: Nephrology Genetics Pathology and Forensic Medicine
Journals: New England Journal of Medicine (1 paper)Journal of the American College of Cardiology (2 papers)Endocrinology (3 papers)
Partner nations: United States Spain Netherlands

In The Last Decade

Holly B. Krasa

42 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Holly B. Krasa

Since Specialization

Citations

This map shows the geographic impact of Holly B. Krasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly B. Krasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly B. Krasa more than expected).

Fields of papers citing papers by Holly B. Krasa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly B. Krasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly B. Krasa. The network helps show where Holly B. Krasa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Holly B. Krasa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Holly B. Krasa Line = papers co-authored together Holly B. Krasa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	National and State Societal Costs of Schizophrenia in the US in 2024 JAMA Psychiatry ·Holly B. Krasa,James R. Baumgardner,Iris Brewer,Jacquelyn W. Chou,Thomas Flottemesch,Jessica T. Markowitz,Cory Williams,(unknown)	2026	0
2	Quantifying the Societal Impacts of Schizophrenia: A Survey of Caregivers PubMed ·Holly B. Krasa,Kelly Birch,Frances Eskew,Theresa Frangiosa,Andrew Palsgrove,Melissa Culhane Maravić	2025	1
3	OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD Kidney International Reports ·Ronald D. Perrone,Dorothee Oberdhan,John Ouyang,Daniel G. Bichet,Klemens Budde,Arlene B. Chapman,Berenice Y. Gitomer,Shigeo Horie,Albert Ong,Vicente E. Torres,Neil Turner,Holly B. Krasa	2023	17
4	Assessing what matters most to patients with or at risk for Alzheimer’s and care partners: a qualitative study evaluating symptoms, impacts, and outcomes Alzheimer s Research & Therapy ·Dana DiBenedetti,Christina Slota,Samantha L. Wronski,George Vradenburg,Meryl Comer,Leigh F. Callahan,John B. Winfield,Ivana Rubino,Holly B. Krasa,Ann Hartry,Dan Wieberg,Ian N. Kremer,Debra Lappin,Allison D. Martin,Terry Frangiosa,Virginia Biggar,Brett Hauber	2020	53
5	Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review Journal of Medical Economics ·Bruce Spinowitz,Roberto Pecoits‐Filho,Wolfgang C. Winkelmayer,Pablo E. Pérgola,Samuel Rochette,Philippe Thompson‐Leduc,Patrick Lefèbvre,Gigi Shafai,Ana Bozas,Myrlene Sanon,Holly B. Krasa	2019	45
6	Chronic hyponatremia and association with osteoporosis among a large racially/ethnically diverse population Osteoporosis International ·Annette L. Adams,B. H. Li,Sunil Bhandari,Siddhesh Kamat,Shirin V. Sundar,Holly B. Krasa,Connie M. Rhee,Kamyar Kalantar‐Zadeh,Steven J. Jacobsen,John J. Sim	2019	7
7	Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument American Journal of Kidney Diseases ·Dorothee Oberdhan,Jason C. Cole,Holly B. Krasa,Rebecca Cheng,Frank S. Czerwiec,Ron D. Hays,Arlene B. Chapman,Ronald D. Perrone	2017	32
8	Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT) American Journal of Kidney Diseases ·Joseph G. Verbalis,Howard Ellison,Mary Hobart,Holly B. Krasa,John Ouyang,Frank S. Czerwiec,Otis Barnum,Karthikeya Devireddy,Miguel Franco,Francis Goldstein,Terrence C. Hack,Kianoosh Kaveh,Ali Khojasteh,John LaFata,Michael Lillestol,Sarah Olelewe,David P. Rosenbaum,Mitchell H. Rosner,Miguel Trevino,W. G. Wells	2016	42
9	Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function American Journal of Kidney Diseases ·Wendy E. Boertien,Esther Meijer,Paul E. de Jong,Gert J. Ter Horst,Remco J. Renken,Eric J. van der Jagt,Peter Kappert,John Ouyang,Gerwin E. Engels,Willem van Oeveren,Joachim Struck,Frank S. Czerwiec,Dorothee Oberdhan,Holly B. Krasa,Ron T. Gansevoort	2015	66
10	Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data ClinicoEconomics and Outcomes Research ·Tyler Knight,Caroline Schaefer,Holly B. Krasa,Dorothee Oberdhan,Arlene B. Chapman,Ronald D. Perrone	2015	21
11	Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC) American Journal of Kidney Diseases ·Ronald D. Perrone,Jon Neville,Arlene B. Chapman,Berenice Y. Gitomer,Dana C. Miskulin,Vicente E. Torres,Frank S. Czerwiec,Eslie Dennis,Bron Kisler,Steve Kopko,Holly B. Krasa,Elizabeth C. LeRoy,Juliana Castedo,Robert W. Schrier,Steve Broadbent	2015	19
12	Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial Nephrology Dialysis Transplantation ·Ron T. Gansevoort,Esther Meijer,Arlene B. Chapman,Frank S. Czerwiec,Olivier Devuyst,Jared J. Grantham,Eiji Higashihara,Holly B. Krasa,John Ouyang,Ronald D. Perrone,Vicente E. Torres	2015	44
13	Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease Kidney International ·María V. Irazabal,Vicente E. Torres,Marie C. Hogan,James F. Glockner,Bernard F. King,Troy G. Ofstie,Holly B. Krasa,John Ouyang,Frank S. Czerwiec	2011	101
14	Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study American Journal of Kidney Diseases ·Vicente E. Torres,Esther Meijer,Kyongtae T. Bae,Arlene B. Chapman,Olivier Devuyst,Ron T. Gansevoort,Jared J. Grantham,Eiji Higashihara,Ronald D. Perrone,Holly B. Krasa,John Ouyang,Frank S. Czerwiec	2011	100
15	Tolvaptan in Autosomal Dominant Polycystic Kidney Disease Clinical Journal of the American Society of Nephrology ·Eiji Higashihara,Vicente E. Torres,Arlene B. Chapman,Jared J. Grantham,Kyongtae T. Bae,Terry Watnick,Shigeo Horie,Kikuo Nutahara,John Ouyang,Holly B. Krasa,Frank S. Czerwiec	2011	120
16	Sonographie der Speicheldrüsen Ultraschall in der Medizin - European Journal of Ultrasound ·K. Hausegger,Holly B. Krasa,W. Pelzmann,R. Grasser,Ch. Frisch,H Simon	2008	9
17	Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction Journal of the American College of Cardiology ·James E. Udelson,Cesare Orlandi,John Ouyang,Holly B. Krasa,Christopher A. Zimmer,Geir Frivold,W. Herbert Haught,Sheiba Meymandi,Cezar Macarie,Dimitar Raef,Patricia Wedge,Marvin A. Konstam,Mihai Gheorghiade	2008	139
18	Efficacy and tolerability of a selective α_2C‐adrenergic receptor blocker in recovery from cold‐induced vasospasm in scleroderma patients: A single‐center, double‐blind, placebo‐controlled, randomized crossover study Arthritis & Rheumatism ·Robert A. Wise,Fredrick M. Wigley,Barbara White,G. Leatherman,Judy Zhong,Holly B. Krasa,Jun‐ichi Kambayashi,Cesare Orlandi,Frank S. Czerwiec	2004	53
19	Thyroid Hormones Act Primarily within the Brain to Promote the Seasonal Inhibition of Luteinizing Hormone Secretion in the Ewe* Endocrinology ·Catherine Viguié,Deborah F. Battaglia,Holly B. Krasa,Lori A. Thrun,Fred J. Karsch	1999	48
20	Endotoxin Inhibits the Reproductive Neuroendocrine Axis While Stimulating Adrenal Steroids: A Simultaneous View from Hypophyseal Portal and Peripheral Blood¹ Endocrinology ·Deborah F. Battaglia,Jennifer M. Bowen,Holly B. Krasa,Lori A. Thrun,Catherine Viguié,Fred J. Karsch	1997	134

About Holly B. Krasa

Holly B. Krasa is a scholar working on Nephrology, Health Informatics and Genetics, having authored 46 papers that have together received 3.2k indexed citations. Recurring topics across this work include Genetic and Kidney Cyst Diseases (18 papers), Electrolyte and hormonal disorders (12 papers), Ion Transport and Channel Regulation (7 papers), Renal Diseases and Glomerulopathies (6 papers), Dialysis and Renal Disease Management (5 papers), Renal and related cancers (5 papers), Genetic Syndromes and Imprinting (4 papers) and Schizophrenia research and treatment (4 papers). The work is most often cited by research in Nephrology (565 citations), Genetics (1.6k citations) and Pathology and Forensic Medicine (569 citations). Holly B. Krasa has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Frank S. Czerwiec, John Ouyang, Vicente E. Torres, Arlene B. Chapman, Ron T. Gansevoort, Ronald D. Perrone, Eiji Higashihara, Jared J. Grantham, Olivier Devuyst and Catherine Viguié. Their work appears in journals such as New England Journal of Medicine, Journal of the American College of Cardiology and Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact